INFINITT Healthcare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	110,023	102,392	95,750	85,860	88,286	78,170
Other Revenue	-	-	-	-	-	-0
Revenue	110,023	102,392	95,750	85,860	88,286	78,170
Revenue Growth (YoY)	10.76%	6.94%	11.52%	-2.75%	12.94%	11.56%
Cost of Revenue	39,800	40,335	37,945	36,691	34,754	32,371
Gross Profit	70,223	62,057	57,805	49,169	53,532	45,799
Selling, General & Admin	37,024	35,478	37,969	34,086	33,565	27,952
Research & Development	7,982	7,745	9,208	8,635	8,039	7,378
Amortization of Goodwill & Intangibles	120.8	124.44	134.47	133.61	138.67	108.5
Other Operating Expenses	342.1	355.52	277.76	254.94	268.2	272.09
Operating Expenses	49,334	47,840	50,281	45,226	45,675	38,691
Operating Income	20,890	14,217	7,524	3,942	7,857	7,108
Interest Expense	-98.65	-106.84	-131.75	-132.38	-121.79	-118.18
Interest & Investment Income	3,424	3,267	3,004	1,779	1,164	743.52
Earnings From Equity Investments	80.11	21.43	-38.63	100.77	22.47	65.12
Currency Exchange Gain (Loss)	872.16	-514.66	3,627	675.15	-698.68	1,836
Other Non Operating Income (Expenses)	355.64	462.87	85.79	-12.43	320.9	2,311
EBT Excluding Unusual Items	25,523	17,346	14,070	6,353	8,544	11,946
Gain (Loss) on Sale of Investments	24,190	17,981	34,039	15,210	-11,648	14,071
Gain (Loss) on Sale of Assets	-2.96	13.93	-30.97	-5.79	0.46	-1.11
Asset Writedown	-	-	-0.08	-	-	-
Other Unusual Items	5.45	-	-	20.38	8.84	8.98
Pretax Income	49,716	35,341	48,079	21,578	-3,095	26,025
Income Tax Expense	8,565	8,588	7,516	3,972	-3,256	3,386
Earnings From Continuing Operations	41,150	26,753	40,562	17,606	160.93	22,639
Earnings From Discontinued Operations	-	-	-2,066	-818.3	-	-
Net Income to Company	41,150	26,753	38,497	16,788	160.93	22,639
Minority Interest in Earnings	-509.46	-348.5	-698.78	-326.95	-29.36	17.65
Net Income	40,641	26,405	37,798	16,461	131.57	22,656
Net Income to Common	40,641	26,405	37,798	16,461	131.57	22,656
Net Income Growth	50.06%	-30.14%	129.63%	12411.29%	-99.42%	239.02%
Shares Outstanding (Basic)	24	24	24	24	24	24
Shares Outstanding (Diluted)	24	24	24	24	24	24
Shares Change (YoY)	0.07%	-0.04%	0.04%	-	-0.19%	0.19%
EPS (Basic)	1666.25	1083.20	1550.00	675.27	5.40	929.44
EPS (Diluted)	1666.25	1083.20	1550.00	675.27	5.00	928.00
EPS Growth	50.02%	-30.12%	129.54%	13405.31%	-99.46%	238.69%
Free Cash Flow	16,272	13,273	11,483	9,556	8,281	15,424
Free Cash Flow Per Share	667.16	544.50	470.89	392.03	339.72	631.52
Gross Margin	63.83%	60.61%	60.37%	57.27%	60.63%	58.59%
Operating Margin	18.99%	13.88%	7.86%	4.59%	8.90%	9.09%
Profit Margin	36.94%	25.79%	39.48%	19.17%	0.15%	28.98%
Free Cash Flow Margin	14.79%	12.96%	11.99%	11.13%	9.38%	19.73%
EBITDA	23,163	16,552	10,118	6,441	10,418	9,468
EBITDA Margin	21.05%	16.17%	10.57%	7.50%	11.80%	12.11%
D&A For EBITDA	2,274	2,335	2,594	2,498	2,561	2,360
EBIT	20,890	14,217	7,524	3,942	7,857	7,108
EBIT Margin	18.99%	13.88%	7.86%	4.59%	8.90%	9.09%
Effective Tax Rate	17.23%	24.30%	15.63%	18.41%	-	13.01%
Advertising Expenses	-	2,091	2,099	1,999	1,695	804.23